CRISTIANI, COSTANZA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 244
EU - Europa 155
AS - Asia 84
SA - Sud America 1
Totale 484
Nazione #
US - Stati Uniti d'America 239
IT - Italia 116
SG - Singapore 58
CN - Cina 19
DE - Germania 11
GB - Regno Unito 8
NL - Olanda 7
HK - Hong Kong 6
SE - Svezia 6
CA - Canada 5
FR - Francia 2
AT - Austria 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
IN - India 1
UA - Ucraina 1
Totale 484
Città #
Chandler 42
Catanzaro 33
Singapore 32
Santa Clara 19
Milan 17
Ashburn 14
Caserta 11
Chicago 11
Lawrence 11
Princeton 11
Aversa 9
Boardman 8
London 7
Hong Kong 6
Naples 5
Vallefiorita 5
Munich 4
Ottawa 4
Wilmington 4
Des Moines 3
Guangzhou 3
Pescara 3
Redmond 3
Rome 3
Aiello Calabro 2
Assago 2
Bari 2
Beijing 2
Cicciano 2
Cisterna di Latina 2
Cosenza 2
Hanover 2
Redwood City 2
Seattle 2
Squillace 2
Taranto 2
Amsterdam 1
Augusta 1
Clearwater 1
Cortale 1
Fayetteville 1
Franklin Square 1
Germantown 1
Helsinki 1
Jiaxing 1
Latina 1
Los Angeles 1
Mountain View 1
Nantong 1
Norwalk 1
Nuremberg 1
Oakland 1
Olomouc 1
Palermo 1
Paris 1
Piano di Sorrento 1
Potomac 1
Pune 1
Reggio Calabria 1
Rockville 1
Shanghai 1
Stalettì 1
Washington 1
Wuhan 1
Wuhu 1
Xuzhou 1
Totale 322
Nome #
Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition. 43
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway. 43
A disposable passive microfluidic device for cell culturing 42
NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma 41
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors 39
A passive microfluidic device for chemotaxis studies 33
T-cell immunity against Severe Acute Respiratory Syndrome Coronavirus 2 proteins in patients with type 1 diabetes 32
An Observational Study on Chronic Pain Biomarkers in Fibromyalgia and Osteoarthritis Patients: Which Role for Mu Opioid Receptor's Expression on NK Cells? 31
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy. 30
NK cells control breast cancer and related cancer stem cell hematological spread 26
Human NK Cell Subsets in Pregnancy and Disease: Toward a New Biological Complexity. 22
Helper Innate Lymphoid Cells-Unappreciated Players in Melanoma Therapy 18
The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real? 18
IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients 16
Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis 14
Combined blood Neurofilament light chain and third ventricle width to differentiate Progressive Supranuclear Palsy from Parkinson's Disease: A machine learning study 14
Serum Oligomeric α-Synuclein and p-tau181 in Progressive Supranuclear Palsy and Parkinson’s Disease 12
Helper Innate Lymphoid Cells-Unappreciated Players in Melanoma Therapy 12
Editorial: A new era: shaping women's metabolic health, fertility, and sex-related cancers 6
Role of the androgen receptor in melanoma aggressiveness 6
Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study 6
New avenues for melanoma immunotherapy: Natural Killer cells? 5
Proximity Elongation Assay and ELISA for the Identification of Serum Diagnostic Biomarkers in Parkinson’s Disease and Progressive Supranuclear Palsy 5
Erythrocytic α-Synuclein in Parkinson’s Disease and Progressive Supranuclear Palsy—A Pilot Study 5
Totale 519
Categoria #
all - tutte 6.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.046


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 0 0 0 0 3 5
2020/202139 0 0 1 0 0 0 1 0 27 10 0 0
2021/202236 1 0 1 6 0 0 1 6 4 9 8 0
2022/2023134 23 6 3 15 12 11 0 11 27 5 15 6
2023/2024116 15 7 6 12 8 17 13 6 0 2 13 17
2024/2025182 33 13 10 3 25 38 17 12 27 3 1 0
Totale 519